Highlights
- Unichem Laboratories shares surged 12.10% to ₹642.00 during Thursday's session.
- The stock touched an intraday high of ₹687.20 with robust trading volumes.
- The latest consolidated quarterly results reflected continued profitability.
- The stock remained well above its 50-day moving average after extending its recent rally.
- RSI entered the higher zone, indicating sustained short-term momentum.
- Investors are watching whether the stock can maintain its breakout above recent highs.
Overview
Unichem Laboratories Limited emerged among the session's top gainers after its shares climbed 12.10% to ₹642.00. The stock opened at ₹610.15, touched an intraday high of ₹687.20, and witnessed elevated trading activity throughout the session. The rally extends the stock's recent upward trend as market participants continue to evaluate the company's financial performance and improving price structure.
Fundamental View
For the quarter ended 31 March 2026, Unichem Laboratories reported consolidated total income of ₹59,859.00 lakh. Profit before tax stood at ₹1,879.00 lakh, while net profit came in at ₹1,091.00 lakh. Earnings per share were reported at ₹1.55. The latest quarterly performance reflects continued profitability, with investors expected to monitor domestic formulations, export growth, product launches, regulatory developments, and operating margins in the coming quarters.
Technical View
The stock is trading comfortably above its 50-day moving average of ₹410.84, highlighting a positive medium-term trend. The 14-day RSI climbed to around 86.00, reflecting elevated momentum following the recent price surge. Trading volumes also strengthened during the session, indicating increased market participation. Price action around the recent highs will remain important in determining whether the ongoing rally can be sustained.
Key Technical Levels
Immediate support is placed near ₹626.00, followed by the next support around ₹610.00. On the upside, immediate resistance is seen near ₹687.20, while the next resistance is positioned around ₹720.00. These levels may influence the stock's near-term price movement.
Risks to Watch
- Regulatory inspections and compliance requirements.
- Pricing pressure in domestic and export markets.
- Currency fluctuations affecting export revenue.
- Raw material cost volatility.
- Broader market sentiment and sector-wide movements.
Summary
Unichem Laboratories extended its recent rally with a double-digit gain, making it one of the day's strongest-performing pharmaceutical stocks. The latest quarterly results reflected continued profitability, while the technical structure remains favourable with the stock trading well above its 50-day moving average. Investors are likely to monitor future earnings, regulatory developments, and the stock's ability to sustain its momentum near recent highs.
FAQs
Q: Why did Unichem Laboratories shares rise over 12% today?
A: The stock advanced sharply on increased market participation, sustained positive price momentum, and continued investor focus on the company's recent performance.
Q: How did Unichem Laboratories perform in the latest quarter?
A: For the quarter ended 31 March 2026, the company reported consolidated total income of ₹59,859.00 lakh and net profit of ₹1,091.00 lakh.
Q: What does the technical setup indicate?
A: The stock is trading above its 50-day moving average, while the RSI has moved into the higher zone, reflecting elevated short-term momentum.
Q: What are the important technical levels to watch?
A: Immediate support is near ₹626.00 and ₹610.00, while resistance is placed around ₹687.20 and ₹720.00.
Q: What factors could influence Unichem Laboratories shares going forward?
A: Investors may watch future quarterly earnings, product launches, regulatory updates, export performance, operating margins, and overall market sentiment.